about
RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibitionHistone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaHuman papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivatorDifferent agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mappingFenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell SpheroidsCellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.Retinoids in the treatment of glioma: a new perspective.Genetic selection for modulators of a retinoic-acid-responsive reporter in human cellsCloning and expression of a novel nuclear matrix-associated protein that is regulated during the retinoic acid-induced neuronal differentiation.Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations.E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.Acute promyelocytic leukemia: from treatment to genetics and back.In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.Endogenous liver carcinogenesis in the rat.Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis.Rethinking the secondary prevention of superficial bladder cancer: is there a role for retinoids?Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cellsTranscription therapy for cancer.In vivo analysis of the molecular genetics of acute promyelocytic leukemia.Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.Cyclin D1 and cancer development in laryngeal premalignancy patients.Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cellsProgress in lung cancer chemoprevention.Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc.First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic.RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancerBlocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acidModulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte developmentAll-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: a case report.Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 OveractivationThe receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal.Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice.
P2860
Q24316899-3968C538-CC48-46DD-BEAD-6403B9B2ABB7Q24671020-EAA79DC1-EE14-4B14-B06B-429606ED896BQ28202210-2A309A5B-AC7D-45F5-A41B-880C54BE62F0Q28378417-BFBD5FF0-FCA7-40C4-9E8F-7EA960EE6460Q28552301-AA62847F-34D9-4FD3-9C11-5176DE82C3A9Q30444981-EBE4B30B-C4EE-4ED9-A317-F5117D775B97Q30464615-93C3DA91-F648-44B3-A0E7-1BB06B42234AQ30908456-FFB87E4A-139D-47B6-B82E-6B8C016E3CA1Q30984828-A028FD7E-5A63-4096-97DA-0FDD53FC14A1Q33388447-3E09AAEE-3601-4E39-B7B7-C9B04E25462BQ33596422-8CAEE599-A48D-4CE7-9FC7-44EE76616EAEQ33728384-6FB97146-DD78-4343-91D5-C9637E9BEC7EQ33739256-3A0B8E12-46EF-4BB1-B73C-154FB372E250Q33739259-9DE9D70F-B15B-40F7-AAE8-082F86952C9EQ33815859-C6B8FCC3-9D5D-4AD2-8AE4-7EF5840AC2E4Q33842950-B15BCE8D-F050-48B5-B759-40EFF0A3CAC9Q33940204-E7E79828-2ADD-4288-BE13-6D7F0F211AF2Q34028770-DEAC78AB-DA52-4150-A8B0-7C57579D2D2AQ34143378-7830E925-A229-400D-8EF2-49A15CC19B61Q34290301-F111FC03-6299-4D01-913E-D7E75789E7B7Q34405484-DA9ECE20-C54C-4A06-AF6D-6103E4EAB294Q34533496-4F0C0669-2741-40CA-93C0-9BC18E64E37BQ34569485-23358406-1CF3-45BA-B085-5D69D5E27095Q34580753-28713DA4-CD49-4A5E-9AB5-773655317C3CQ34977383-968EC946-01F6-471D-8BD8-A5CDDC10A3EAQ35154604-BF08D1F4-A60B-4789-B4D1-383F47DF5C6FQ35198453-6AC4CA96-E2A6-42B5-9941-F6B34A68C721Q35590462-F754A998-8AED-4CD2-94AD-7FB5DD774083Q35675265-49211220-6041-4D52-826A-7E8D170DB2B1Q35782377-401917D7-E293-47EE-863F-F71F74127E0AQ35906240-1FA8BDED-FB3F-4B78-B3E8-5212B8A51FA9Q36136230-08FB0D10-40F7-4648-80F8-9A00BBA29712Q36159570-6606BE89-EF6B-4DF4-8C79-96D51C218D09Q36293028-E6270C77-D134-48BF-8F16-7B8406260160Q36397870-F1A92599-BB80-413D-A474-833479865F72Q36431663-B80B981E-13B9-4FB3-B1FE-644F01D5670AQ36462605-0ACC12A8-05A0-4501-B0B5-7E421A2EA666Q36495910-FA5A0CC1-532F-464B-A116-BAA0170C80FAQ36561262-A9A8C881-CE9B-4BA4-B5CF-AD8A4F9D00CBQ36613829-E9176CD6-2D82-436B-912E-05D5EBEF07DB
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Retinoids in cancer therapy.
@ast
Retinoids in cancer therapy.
@en
type
label
Retinoids in cancer therapy.
@ast
Retinoids in cancer therapy.
@en
prefLabel
Retinoids in cancer therapy.
@ast
Retinoids in cancer therapy.
@en
P2093
P1476
Retinoids in cancer therapy.
@en
P2093
B D Cheson
D R Parkinson
M A Friedman
P304
P356
10.1200/JCO.1992.10.5.839
P407
P577
1992-05-01T00:00:00Z